Tablet manufacturing for supplements: types, tests and TGO 101
In short
- Supplement tablets can be direct-compression, film-coated, chewable, effervescent, orally disintegrating, sublingual, bilayer or extended-release. The choice follows the dose, the taste and how the actives should release.
- A tablet suits a high dose, a taste that needs masking, a blend too wet to encapsulate, or customers who won't swallow a capsule.
- A listed tablet must meet TGO 101 throughout its shelf life: each active within its assay limits (90.0 to 120.0% of the label claim by default, wider for vitamins, minerals and enzymes), uniformity of weight, and a disintegration or dissolution test.
- Chewable tablets don't take the disintegration test. Modified-release tablets, and most tablets with 100 micrograms or more of folic acid, take a dissolution test.
- From our records: a 500 mg single-ingredient tablet, a practitioner tablet with five production batches, a capsule rescued as a direct-compression tablet, and a two-a-day prenatal chewable.
The kinds of supplement tablet
| Tablet | What it is | Popular for |
|---|---|---|
| Direct-compression | The blend pressed straight into a tablet, without granulating first | Single actives and blends that flow and compress well |
| Film-coated | A thin coating over the core, for swallowing, taste or protection | Larger tablets and bitter or strong-smelling actives |
| Chewable | Made to be chewed, with the taste masked | Prenatals, children's and adults who won't swallow |
| Effervescent | Dissolved in water before taking | Vitamin C and electrolytes |
| Orally disintegrating and sublingual | Dissolve in the mouth or under the tongue | Small doses taken without water |
| Bilayer | Two layers in one tablet, to keep actives apart or release them differently | Combinations that don't sit well together |
| Extended-release | Releases its actives over time | Actives meant to work over hours |
When a tablet is the right format
The format follows the formula, the dose and the customer, and sometimes the production line decides. From our records:
- The dose is high. A tablet carries more dose in one unit: Your Skin Scan's product is a single 500 mg nicotinamide tablet.
- The blend won't encapsulate. An eye-health formula kept failing in encapsulation because the mix was too wet; hand-filling would have added one to two months. We moved it to a direct-compression tablet mid-project.
- The taste needs masking. B vitamins and selenium are bitter and smell strongly. Arxi's prenatal moved from a liquid drop to a two-a-day chewable with Rocoat® coated B vitamins to tame the taste.
- The customer won't swallow a capsule. A chewable or an effervescent tablet solves it. For a softer chew, see gummies.
A capsule is usually quicker to develop and suits powders and extracts at moderate doses; a softgel suits oils (capsule manufacturing, softgel manufacturing).
What TGO 101 requires of a listed tablet
TGO 101 is the TGA's standard for tablets, capsules and pills. Where an applicable British, European or US pharmacopoeia monograph exists, a tablet can follow it; otherwise a listed tablet meets the order's own requirements, throughout its shelf life.
Assay. Each active ingredient must assay within limits of the content stated on the label, tested on a pooled sample of at least 20 tablets:
| Active ingredient | Limits for a listed medicine |
|---|---|
| Default | 90.0 to 120.0% |
| Water-soluble vitamins | 90.0 to 150.0% |
| Oil-soluble vitamins | 90.0 to 165.0% |
| Betacarotene, panthenol, pantothenic acid or its salts | 90.0 to 175.0% |
| Minerals | 90.0 to 160.0% |
| Boron, chromium, fluorine, iodine, molybdenum or selenium | 90.0 to 125.0% |
| Enzymes | 90.0 to 200.0% |
| Probiotics | Not less than the stated content |
Disintegration. Tablets other than chewables must pass a disintegration test, by the European or US pharmacopoeia method, unless the order calls for a dissolution test instead. A dispersible tablet also passes the British Pharmacopoeia's fineness of dispersion test.
Dissolution. A modified-release tablet must pass a dissolution test showing each active releases as it should. A tablet with 100 micrograms or more of folic acid takes a dissolution test, unless it is chewable, effervescent, dispersible or modified-release.
Uniformity of weight. A listed tablet passes a uniformity of weight test.
Elemental impurities and residual solvents. Since 31 March 2021, limits apply under the ICH Q3D guideline or the US pharmacopoeia, and residual solvents under the European pharmacopoeia.
Not every test must be run on every batch: the TGA says the medicine's design, control strategy and validation or stability data can show the standard will be met. The full picture of batch testing is in our supplement quality testing guide.
Stability and the shelf life
A tablet's shelf life on the label rests on its stability program, and it must still meet TGO 101 at the end of it. For the eye-health tablet in our records, we designed the stability protocol to support a three-year expiry; for BWellness's tablet, the program tested at 3 and 12 months. What the TGA expects is in our stability testing guide.
From our records
- Your Skin Scan: a single-ingredient 500 mg nicotinamide tablet, 120 per bottle, as a TGA-listed medicine. From signed quote to delivery: about 6.5 months.
- BWellness: a 60-tablet formula built on EnXtra®, a clinically studied Alpinia galanga extract, with five production batches from 2021 to 2025 and a sixth order in the pipeline.
- An eye-health formula moved from a capsule that wouldn't fill to a direct-compression tablet, with a stability protocol designed for a three-year expiry. It shipped in 2024.
- Arxi's prenatal chewable: a two-a-day chewable with coated B vitamins, after a liquid drop proved unstable. Our label review caught two errors before print.
Questions
Frequently asked questions
Direct-compression, film-coated, chewable, effervescent, orally disintegrating, sublingual, bilayer and extended-release tablets.
It depends on the formula. A tablet suits a high dose, taste masking, controlled release or a blend too wet to encapsulate; a capsule suits powders and extracts at moderate doses and is usually quicker to develop.
A listed tablet meets TGO 101: each active within its assay limits, uniformity of weight, and a disintegration test, or a dissolution test for modified-release tablets and most with 100 micrograms or more of folic acid. Chewables don't take the disintegration test.
Yes, though in the TGA's change tables a change of dosage form makes a new medicine, so it needs a new listing (reformulating a supplement).
Ours is 3,000 finished retail packs per batch. A production run takes 12 to 14 weeks once the specification is signed (managed manufacturing).
Case studies
Case studies
An own-brand launch for a clinical skin service
A first own-brand product, from first enquiry to delivery within the year
Read the story →Nine products and a long partnership
Five production batches from 2021 to 2025
Read the story →Rescuing a product that wouldn't encapsulate
The eye-health tablet shipped in 2024
Read the story →Making a prenatal people will actually take
In production, due for dispatch in late October 2026
Read the story →Keep reading
Keep reading
Softgel manufacturing for supplements: oils, shells and the tests
Softgel manufacturing in Australia: which actives suit a softgel, gelatin, vegan, chewable and enteric shells, the TGO 101 tests, and softgels from our records.
TGA advertising rules for supplements: the Code, influencers and penalties
How the TGA's Advertising Code applies to a supplement: what counts as advertising, required statements, testimonials, influencers, social media and penalties.
Labelling a supplement in Australia: what TGO 116 requires
TGA labelling requirements for supplements under TGO 116: the main label, other required information, text size, warnings, allergens and the transition.
How to choose a supplement manufacturer in Australia
Choosing a supplement manufacturer in Australia: what a TGA licence covers and how to check it, sites overseas, the GMP agreement and how each batch is tested.
Sources
General information, checked against these sources on 18 November 2026. It isn't advice on a particular product. Our work, minimums and timings are from Take Friday Off's records.
- Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TGO 101) Order 2019, sections 2, 6, 9, 13 to 20 and Schedules 1 and 2, Federal Register of Legislation
- Complying with quality standards for tablets, capsules and pills, May 2025, Therapeutic Goods Administration, as set out in our guide to choosing a supplement manufacturer
- Changing a listed or assessed listed medicine: application types and change tables, version 2.2, March 2022, Therapeutic Goods Administration
